AllCells’ scientists will remain part of Discovery, and all ongoing studies will continue to be serviced by those same dedicated experts. The flow of projects and timelines will be unaffected by the acquisition.
White Paper - Companion Diagnostic Development: An Overview
Primary Human Mast Cells are Now Available
Xenium In Situ Services are Now Available
Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments
Advancing In Vitro Disease Modeling with Mouse Hepatocytes for Gene Therapy
White Paper - Companion Diagnostic Development: An Overview
Primary Human Mast Cells are Now Available
Xenium In Situ Services are Now Available
Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments
Advancing In Vitro Disease Modeling with Mouse Hepatocytes for Gene Therapy